1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Development
1.2.3 API Production
1.3 Market by Application
1.3.1 Global Small Molecule CDMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Biopharmaceutical
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule CDMO Market Perspective (2018-2029)
2.2 Small Molecule CDMO Growth Trends by Region
2.2.1 Global Small Molecule CDMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Small Molecule CDMO Historic Market Size by Region (2018-2023)
2.2.3 Small Molecule CDMO Forecasted Market Size by Region (2024-2029)
2.3 Small Molecule CDMO Market Dynamics
2.3.1 Small Molecule CDMO Industry Trends
2.3.2 Small Molecule CDMO Market Drivers
2.3.3 Small Molecule CDMO Market Challenges
2.3.4 Small Molecule CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule CDMO Players by Revenue
3.1.1 Global Top Small Molecule CDMO Players by Revenue (2018-2023)
3.1.2 Global Small Molecule CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Small Molecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule CDMO Revenue
3.4 Global Small Molecule CDMO Market Concentration Ratio
3.4.1 Global Small Molecule CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CDMO Revenue in 2022
3.5 Small Molecule CDMO Key Players Head office and Area Served
3.6 Key Players Small Molecule CDMO Product Solution and Service
3.7 Date of Enter into Small Molecule CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule CDMO Breakdown Data by Type
4.1 Global Small Molecule CDMO Historic Market Size by Type (2018-2023)
4.2 Global Small Molecule CDMO Forecasted Market Size by Type (2024-2029)
5 Small Molecule CDMO Breakdown Data by Application
5.1 Global Small Molecule CDMO Historic Market Size by Application (2018-2023)
5.2 Global Small Molecule CDMO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Small Molecule CDMO Market Size (2018-2029)
6.2 North America Small Molecule CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Small Molecule CDMO Market Size by Country (2018-2023)
6.4 North America Small Molecule CDMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule CDMO Market Size (2018-2029)
7.2 Europe Small Molecule CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Small Molecule CDMO Market Size by Country (2018-2023)
7.4 Europe Small Molecule CDMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule CDMO Market Size (2018-2029)
8.2 Asia-Pacific Small Molecule CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Small Molecule CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Small Molecule CDMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule CDMO Market Size (2018-2029)
9.2 Latin America Small Molecule CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Small Molecule CDMO Market Size by Country (2018-2023)
9.4 Latin America Small Molecule CDMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule CDMO Market Size (2018-2029)
10.2 Middle East & Africa Small Molecule CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Small Molecule CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Small Molecule CDMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Small Molecule CDMO Introduction
11.1.4 Lonza Revenue in Small Molecule CDMO Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule CDMO Introduction
11.2.4 Catalent Revenue in Small Molecule CDMO Business (2018-2023)
11.2.5 Catalent Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Small Molecule CDMO Introduction
11.3.4 Thermo Fisher Revenue in Small Molecule CDMO Business (2018-2023)
11.3.5 Thermo Fisher Recent Development
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Detail
11.4.2 Wuxi Apptec Business Overview
11.4.3 Wuxi Apptec Small Molecule CDMO Introduction
11.4.4 Wuxi Apptec Revenue in Small Molecule CDMO Business (2018-2023)
11.4.5 Wuxi Apptec Recent Development
11.5 PharmaBlock
11.5.1 PharmaBlock Company Detail
11.5.2 PharmaBlock Business Overview
11.5.3 PharmaBlock Small Molecule CDMO Introduction
11.5.4 PharmaBlock Revenue in Small Molecule CDMO Business (2018-2023)
11.5.5 PharmaBlock Recent Development
11.6 Asym Chemical
11.6.1 Asym Chemical Company Detail
11.6.2 Asym Chemical Business Overview
11.6.3 Asym Chemical Small Molecule CDMO Introduction
11.6.4 Asym Chemical Revenue in Small Molecule CDMO Business (2018-2023)
11.6.5 Asym Chemical Recent Development
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Detail
11.7.2 Jiuzhou Pharmaceutical Business Overview
11.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Introduction
11.7.4 Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2018-2023)
11.7.5 Jiuzhou Pharmaceutical Recent Development
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Detail
11.8.2 Pharmaron Beijing Business Overview
11.8.3 Pharmaron Beijing Small Molecule CDMO Introduction
11.8.4 Pharmaron Beijing Revenue in Small Molecule CDMO Business (2018-2023)
11.8.5 Pharmaron Beijing Recent Development
11.9 Porton Pharma
11.9.1 Porton Pharma Company Detail
11.9.2 Porton Pharma Business Overview
11.9.3 Porton Pharma Small Molecule CDMO Introduction
11.9.4 Porton Pharma Revenue in Small Molecule CDMO Business (2018-2023)
11.9.5 Porton Pharma Recent Development
11.10 ChemPartner
11.10.1 ChemPartner Company Detail
11.10.2 ChemPartner Business Overview
11.10.3 ChemPartner Small Molecule CDMO Introduction
11.10.4 ChemPartner Revenue in Small Molecule CDMO Business (2018-2023)
11.10.5 ChemPartner Recent Development
11.11 Jiangsu Sinopep
11.11.1 Jiangsu Sinopep Company Detail
11.11.2 Jiangsu Sinopep Business Overview
11.11.3 Jiangsu Sinopep Small Molecule CDMO Introduction
11.11.4 Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2018-2023)
11.11.5 Jiangsu Sinopep Recent Development
11.12 DELPHARM
11.12.1 DELPHARM Company Detail
11.12.2 DELPHARM Business Overview
11.12.3 DELPHARM Small Molecule CDMO Introduction
11.12.4 DELPHARM Revenue in Small Molecule CDMO Business (2018-2023)
11.12.5 DELPHARM Recent Development
11.13 Aenova Group
11.13.1 Aenova Group Company Detail
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Small Molecule CDMO Introduction
11.13.4 Aenova Group Revenue in Small Molecule CDMO Business (2018-2023)
11.13.5 Aenova Group Recent Development
11.14 Siegfried Holding AG
11.14.1 Siegfried Holding AG Company Detail
11.14.2 Siegfried Holding AG Business Overview
11.14.3 Siegfried Holding AG Small Molecule CDMO Introduction
11.14.4 Siegfried Holding AG Revenue in Small Molecule CDMO Business (2018-2023)
11.14.5 Siegfried Holding AG Recent Development
11.15 Recipharm AB
11.15.1 Recipharm AB Company Detail
11.15.2 Recipharm AB Business Overview
11.15.3 Recipharm AB Small Molecule CDMO Introduction
11.15.4 Recipharm AB Revenue in Small Molecule CDMO Business (2018-2023)
11.15.5 Recipharm AB Recent Development
11.16 FAREVA SA
11.16.1 FAREVA SA Company Detail
11.16.2 FAREVA SA Business Overview
11.16.3 FAREVA SA Small Molecule CDMO Introduction
11.16.4 FAREVA SA Revenue in Small Molecule CDMO Business (2018-2023)
11.16.5 FAREVA SA Recent Development
11.17 Almac Group
11.17.1 Almac Group Company Detail
11.17.2 Almac Group Business Overview
11.17.3 Almac Group Small Molecule CDMO Introduction
11.17.4 Almac Group Revenue in Small Molecule CDMO Business (2018-2023)
11.17.5 Almac Group Recent Development
11.18 Cambrex
11.18.1 Cambrex Company Detail
11.18.2 Cambrex Business Overview
11.18.3 Cambrex Small Molecule CDMO Introduction
11.18.4 Cambrex Revenue in Small Molecule CDMO Business (2018-2023)
11.18.5 Cambrex Recent Development
11.19 Charles River
11.19.1 Charles River Company Detail
11.19.2 Charles River Business Overview
11.19.3 Charles River Small Molecule CDMO Introduction
11.19.4 Charles River Revenue in Small Molecule CDMO Business (2018-2023)
11.19.5 Charles River Recent Development
11.20 CORDEN PHARMA
11.20.1 CORDEN PHARMA Company Detail
11.20.2 CORDEN PHARMA Business Overview
11.20.3 CORDEN PHARMA Small Molecule CDMO Introduction
11.20.4 CORDEN PHARMA Revenue in Small Molecule CDMO Business (2018-2023)
11.20.5 CORDEN PHARMA Recent Development
11.21 Jubilant Pharmova
11.21.1 Jubilant Pharmova Company Detail
11.21.2 Jubilant Pharmova Business Overview
11.21.3 Jubilant Pharmova Small Molecule CDMO Introduction
11.21.4 Jubilant Pharmova Revenue in Small Molecule CDMO Business (2018-2023)
11.21.5 Jubilant Pharmova Recent Development
11.22 Consort Medical
11.22.1 Consort Medical Company Detail
11.22.2 Consort Medical Business Overview
11.22.3 Consort Medical Small Molecule CDMO Introduction
11.22.4 Consort Medical Revenue in Small Molecule CDMO Business (2018-2023)
11.22.5 Consort Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
